Check-Cap Ltd.
MBAIStockNASDAQ
$1.39 ▲ +1.46%
12 juin 2026
M
Check-Cap Ltd.
$1.39 ▲ +1.46%
12 juin 2026
MBAIStockNASDAQ

01 / À propos

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Arberion
Loading market data